Insulin growth factor I (IGF-I) appears necessary for the completion of follicular development in mice. However, little is known about changes in the IGF system components during follicular development and luteinization. This study determined the relation between gene expression of specific IGF system components and follicular growth, survival, or atresia in mice. Immature mice from three different strains (129, C57, and MF1), with or without gonadotropin treatment [2.5 IU PMSG/2.5 IU human CG (hCG)], were used. The strains were similar in all parameters measured. Apoptosis, as detected by in situ labeling of nicked DNA, preceded the appearance of morphological signs of atresia. In healthy follicles, IGF-I transcripts were low during the primary follicular stage but increased to a maximum in the late preantral and early antral stages (P Ͻ 0.001) irrespective of hormone treatment. Occasionally, IGF-I transcripts were also detected in apoptotic follicles but decreased (P Ͻ 0.05) as a function of atresia as assessed by morphological criteria. IGF binding protein-4 (IGFBP-4) messenger RNA (mRNA) expression in granulosa cells was restricted to apoptotic and atretic follicles (P Ͻ 0.001). IGFBP-5 transcript levels, on the other hand, were elevated in granulosa cells of healthy primary and secondary follicles but decreased in subsequent follicular stages and in atretic follicles (P Ͻ 0.001). Conversely, IGFBP-2 mRNA was constitutively expressed in granulosa cells.
D ELETION of the insulin growth factor I (IGF-I) gene
leads to failure of ovarian follicles to ovulate (1), demonstrating that IGF-I is required for follicular development beyond the antral stage and for completion of oocyte growth and maturation. It has been postulated that the primary role of intraovarian IGF-I is to amplify FSH action in vivo, because similar effects have been demonstrated on cultured granulosa cells (1) (2) (3) . All these observations have led to the suggestion that the ultimate fate of the follicle, i.e. growth or atresia, will depend on intrafollicular synthesis and availability of IGF-I to interact with its cognate receptor, the IGF type-I receptor (IGF-IR) (4) . The bioavailability of IGF-I in the ovary is regulated by several IGF binding proteins (IGFBPs 2-6) (5) (6) (7) (8) . These components of the intraovarian IGF system have been well documented in rodents, especially rats (6, 9 -15) . Considerably less information is available about the mouse (1, 16, 17) .
A more definitive characterization of the murine ovarian IGF system is warranted for several reasons. First, the relevance of the rat intraovarian IGF system to mouse physiology is uncertain; for instance, IGFBP-2 messenger RNA (mRNA) is expressed in the rat thecal-interstitial compartment, but apparently restricted to granulosa cells in the mouse ovary (16) . It has been suggested that IGF-I mRNA expression in mouse ovaries is restricted to healthy follicles (16) , but the histological assessment of follicular health or atresia was not documented in this study. Thirdly, to the best of our knowledge, the existence of a correlation between specific IGFBPs and follicular growth or atresia in the murine ovary has never been addressed. Follicular atresia is associated with the appearance of IGFBP-4 and -5 transcripts in rat granulosa cells (12) (13) (14) and increases in IGFBP-2, -4, and -5 in sheep antral follicles (18) . In the pig, IGFBP-2 seems most tightly correlated with atresia (19) . Finally, previous studies in the mouse were conducted in immature animals; thus, nothing is known about gonadotropin-induced changes in the expression of IGF system components or levels in preovulatory follicles and luteal cells. A more extensive characterization of murine intraovarian IGFs and their receptor and binding proteins also would provide a firm basis for interpreting ongoing studies assessing reproductive effects of mutations in the IGF system in mice.
Materials and Methods Animals
Immature (4 weeks of age) MF1, C57, and 129 mice (purchased from The Jackson Laboratory, Bar Harbor, ME) were killed by cervical dislocation and their ovaries collected, immediately placed in plastic molds containing embedding medium (Fisher Scientific International, Inc. Morris Plains, NJ), and frozen over liquid nitrogen. In selected experiments, animals received a 2.5-IU ip injection of PMSG (T ϭ 0) followed by 2.5 IU of human CG (hCG) (T ϭ 48 h), and were killed 24 h later (T ϭ 72 h). Ovaries were removed and immediately frozen over liquid nitrogen vapors. Frozen ovaries were kept at Ϫ70 C until sectioned at 8 m thickness in a cryostat at Ϫ18 C, thaw-mounted onto Superfrost Plus microslides (Fisher Scientific International, Inc.), air dried, and stored at Ϫ70 C until used for in situ hybridization or in situ end labeling of apoptotic cells. Sections were transferred directly from Ϫ70 C into 4% paraformaldehyde/PBS, rinsed in PBS, dehydrated in a series of alcohols, acetylated in 0.25% acetic anhydride (vol/vol), 0.05 m triethanolamine, 0.3% acetic acid for 10 min, washed in 0.2ϫ SSC (1ϫSSC contains 0.15 m sodium chloride, 0.015 m sodium citrate), and dehydrated. Sections were prehybridized 1-3 h at room temperature (RT) in 50% deionized formamide; 0.6 m NaCl; 10 mm Tris HCl, pH 7.5; 0.02% Ficoll; 0.02% BSA; 0.02% polyvinylpyrrolidone; 1 mm EDTA; 0.1% sheared herring sperm DNA; 0.5 mg/ml yeast total RNA; and 0.05 g/ml transfer RNA. Next, hybridization was carried out overnight at 50 C in prehybridization buffer containing 35 S-labeled cRNA probe (4 ϫ 10 7 cpm/ml), 0.1 mg/ml sheared herring sperm DNA, 10% dextran sulfate, 0.1% SDS, and 10 mm dithiothreitol. Sections were rinsed subsequently in 2ϫ SSC and washed in 50% formamide, 1ϫ SSC, and 10 mm dithiothreitol at 45 C and O.5ϫ SSC at RT. Unhybridized probe was then degraded by ribonuclease A [100 mg/mL in 0.5 m NaCl; 10 mm Tris, pH 7.5; and 1 mm EDTA] for 30 min at RT, and sections were washed in 0.2ϫ SSC at 55-60 C for 2 h and dehydrated through graded alcohols. Sections were exposed to autoradiographic film (Kodak Biomax MR, Eastman Kodak Co., Rochester, NY) overnight to evaluate the intensity of hybridization signals, then dipped in Kodak NTB2 liquid emulsion and exposed for 1-3 weeks depending on the probe at 4 C. For a given probe, exposure times were the same for all animals. This were 3 weeks for IGF-I, -II, -IR, IGFBP-2, and -3 and 1 week for IGFBP-4 and -5. Slides were developed in Kodak-D19 developer and counterstained with Mayer's hematoxylin and examined with both bright-field and dark-field microscopy.
In situ hybridization

Quantitative analysis of in situ hybridization
Quantitative analysis of hybridization signals was performed using a video-NIH Image Analysis program (Scion Corp., Frederick, MD) linked to a microscope. Each probe was tested simultaneously on three different mouse strains, and three to four animals were examined per strain and per probe. For each animal and for each probe, one representative section was chosen in the largest cross-section of the ovary. Grain density was determined in a constant area of 200 m 2 using a ϫ20 objective and dark-field illumination. Under these conditions, there was excellent correlation between the number of silver grains determined by visual count and image analysis. Grain density was determined in four nonoverlapping constant (200 m 2 ) areas of primary or preantral follicles. Six such areas were considered for antral follicles and corpora lutea. Only microscopic fields completely occupied with cells were measured, except for the background for which grain density was determined in four large random areas (5000 m 2 ) devoid of tissues. For each slide, specific labeling was determined by subtracting average background value from the values obtained for each follicular category. For sense probes, the specific hybridization signal determined using these methods was negligible.
Morphological characterization of ovarian follicles
Stages of follicular development were defined as follows: primary (a single layer of cuboidal granulosa cells), large preantral (at least two layers of cuboidal granulosa cells and no antrum), small antral (several layers of granulosa cells and one or several small antral cavities but no cumulus oophorus stalk), and large antral (several layers of granulosa cells, a single large antral cavity, and a well-defined cumulus oophorus stalk). In preliminary studies, IGFBP-5 mRNA expression was heterogenous between subclasses of the preantral stage. Consequently, for IGFBP-5, the large preantral stage was further divided into secondary (two layers of granulosa cells) and tertiary (three or more layer of granulosa cells and no antral cavity).
Follicles were classified as healthy on the following basis: zero (primary follicles) to no more than three pyknotic nuclei (preantral and antral follicles), granulosa cells regularly apposed on an intact basement membrane, no fibroblastic morphology in the granulosa cell compartment, and no evidence of infiltration of the oocyte by somatic cells. Follicles were classified as early atretic if they contained at least one pyknotic nucleus in primary and four in larger follicles and an irregular basal lamina. In addition to these criteria, late atretic follicles also contained fibroblast cell in the granulosa cell compartment and oocyte infiltration by somatic cells. Other criteria for assessing follicular atresia such as dissolution of germinal vesicle, chromatin condensation, or cytoplasmic fragmentation of the oocyte were not easy to apply in these studies because the integrity of these cellular compartments is not well preserved in frozen sections.
Only follicles with a visible oocyte were considered to ensure proper follicular counting and classification. A total of 33-35 primary, 30 -51 healthy preantral, 18 -49 early atretic preantral, 6 -40 late atretic preantral, 12-26 small antral, and 0 -12 large antral follicles (large antral follicles were not apparent in many sections of immature animals) were analyzed depending on the IGF system component considered.
In situ end labeling of apoptotic nuclei
Two related but distinct procedures were used to detect apoptosis in ovarian tissues. These procedures used either the enzyme terminal deoxynucleotidyl transferase (TUNEL) or the Klenow fragment of DNA polymerase I (KLUNEL) to catalyze the transfer of digoxygenin (DIG)-labeled nucleotides to the 3ЈOH end of fragmented DNA. The KLUNEL procedure has been validated in a variety of tissues (26, 27) but not in the ovary. Conversely, the use of the TUNEL procedure to detect apoptosis in ovaries has been previously documented (28 -30) . Sections were processed identically for the two procedures except for some differences in enzyme buffers. For the TUNEL procedure, sections were incubated for 1 h in a buffer containing 300 U/ml Tdt 300 mm NaCl, 30 mm sodium citrate (TUNEL), or buffer 1 containing 0.3% Triton X-100 (KLUNEL) at RT. The remaining steps were identical for both procedures. Sections were incubated with a 1:500 dilution of an alkaline phosphatase-conjugated sheep anti-DIG antibody for 1 h at 37 C, and the alkaline phosphatase reaction developed in BCIP/NBT (Boehringer-Mannheim) for 45 sec, followed by counterstaining with 1% methyl green.
In one series of experiments, consecutive ovarian sections from five mice were compared sequentially with the TUNEL and KLUNEL procedures. The same population of follicles were labeled on adjacent sections using either DNA fragmentation assay. In a second series of experiments, consecutive ovarian sections from five mice were used sequentially for in situ hybridization and in situ end labeling (KLUNEL) to determine whether or not granulosa cells expressing IGF-I or IGFBP-2 or -4 transcripts were apoptotic.
Statistical analyses
The data presented are expressed as the mean Ϯ sem. Repeated measures ANOVA models were used to assess differences between mean densities, adjusted for the average background density, within and between follicle categories (primary through antral, healthy, and atretic) and mouse strains for each probe (IGF-I and IGFBP-2, -4, or -5), and for untreated and hormone-treated mouse groups. No differences were observed between MF1, C57, and 129 for IGF-I or IGFBP-2, -4, or -5, and consequently, results were pooled across the strains. The covariance structure of the models accounted for both within-and between-mouse correlation (31) . Bonferroni adjustments were made to P values and confidence intervals for the contrasts of interest to adjust for multiple comparisons such that the overall probability of a type I error (␣) was 0.05. All analyses were performed using the SAS statistical package (SAS Institute, Inc., Cary, NC). 
Results
Cellular expression of components of IGF system during growth of healthy follicles
The in situ expression of various components of the IGF system was similar in three different mouse strains (129, C57, and MF1). IGF-I mRNA expression was restricted to the granulosa cell compartment of a set of follicles in untreated ( Fig. 1) and hormone-treated immature mice ( Fig. 2A) . In morphologically healthy follicles, IGF-I mRNA levels were lower (P Ͻ 0.001) in primary follicles than in larger preantral and antral follicles in untreated (Fig. 3) and hormone-treated immature mice (not shown). In granulosa cells of healthy antral follicles, IGF-I mRNA was expressed as a gradient; the signal was stronger in the cumulus oophorus and in the vicinity of the antrum than in the mural compartment (P Ͻ 0.001; Fig. 3 ). Irrespective of hormonal treatment, IGF-II mRNA signal was mainly expressed in ovarian blood vessels; in addition, there was minor diffuse signal in the rest of the ovary (data not shown).
In untreated (Fig. 1 ) and gonadotropin-treated immature mice ( Fig. 2A) , IGFBP-2 mRNA was detected in the granulosa cell compartment of most follicles from the primary to antral stage. IGFBP-2 transcripts were also present in some primordial follicles (not shown). In healthy follicles, the level of IGFBP-2 transcripts did not change as a function of follicular development (Fig. 4) . A strong induction of IGFBP-2 mRNA expression was also observed in the ovarian interstitium of PMSG/hCG-treated ( Fig. 2A) but not of untreated immature mice (Fig. 1) .
IGF-IR mRNA was constitutively expressed in the granulosa cell compartment of most follicles from all stages, from primary to antral, healthy or atretic (Figs. 1 and 2A) . IGFBP-3 mRNA was strongly expressed in some interstitial cells and isolated cells-presumably endothelial-in the thecal compartment of some large preantral and antral follicles in untreated (Fig. 1 ) and hormone-treated mice (Fig. 2, A and B) . Modest and relatively constant levels of IGFBP-3 transcripts were also detected in peripheral follicular cells at all stages of follicular development (Fig. 2B) . IGFBP-4 transcripts were constitutively expressed in the thecal and interstitial compartments in ovaries of untreated ( Fig. 1 ) and hormone-treated mice ( Fig. 2A) . However, in granulosa cells of healthy follicles, IGFBP-4 transcripts were very low throughout follicular development (Figs. 1, 2A, and 4) .
Irrespective of hormone treatment, IGFBP-5 transcript levels were highest in the germinal epithelium of the ovary and in granulosa cells of healthy follicles during the primary and secondary stages but decreased sharply (P Ͻ 0.001) in late preantral and subsequent stages (Figs. 1, 2A , and 5). A closer examination revealed IGFBP-5 mRNA expression as early as the primordial follicular stage (not shown).
In summary, the localization of expression for most IGF system components was relatively constant during follicle growth. Changes in the location of expression was noted for IGFBP-2, which appeared in the interstitium after hormonal treatment. Changes in intensity of expression were most notable for IGF-I, which increased with follicle growth and IGFBP-5 which showed a biphasic profile.
IGF-I and IGFBP-2, -4, and -5 mRNA expression in relation to follicular atresia
The levels of IGF-I and IGFBP-2, -4, and -5 mRNA were determined quantitatively as a function of histological criteria for follicular health or atresia. There was an inverse relationship between the levels of IGF-I mRNA expression and the stage of atresia in preantral follicles of untreated (P Ͻ 0.05; Fig. 6 ) or gonadotropin-treated immature (P Ͻ 0.01; results not shown) mice. There was no difference in the level of IGFBP-2 mRNA expression between healthy and early atretic follicles during the preantral stage, but there was a decrease in IGFBP-2 expression in late atretic stages (P Ͻ 0.05; Fig. 6 ). In granulosa cells, IGFBP-4 transcripts were very low in healthy preantral (Fig. 6 ) and antral (results not shown) follicles but increased proportionally with the stage of atresia (P Ͻ 0.001, Fig. 6 ). These results are in contrast with constitutive expression in the theca noted above. IGFBP-5 mRNA expression was highest in healthy primary and secondary follicles and decreased with each stage of atresia (P Ͻ 0.001, Fig. 7 ).
IGF-I and IGFBP-2 and -4 mRNA expression in relation to apoptosis of granulosa cells
Programmed cell death is the mechanism leading to initiation and progression of follicle cell atresia (32, 33) . Therefore, it was further hypothesized that DNA fragmentation would be linked to a decrease in IGF-I mRNA or an increase in IGFBP-2 or -4 transcripts in follicle cells. In preliminary studies, two DNA fragmentation assays (TUNEL) and (KLUNEL) tested on consecutive sections produced similar results (Fig. 8) . The presence of apoptotic cells clearly preceded morphological signs of atresia. On the other hand, follicles showing morphological signs of atresia also contained apoptotic granulosa cells, except for some late stage atretic follicles that were completely depleted of granulosa cells. When consecutive sections were used sequentially for in situ hybridization (IGF-I or IGFBP-2 or -4 mRNA) and in situ end labeling (KLUNEL) of fragmented DNA, IGF-I mRNA was always expressed in healthy follicles with at least two layers of granulosa cells, but occasionally, a positive signal was also detected in apoptotic follicles (Figs. 9, A and  B) . Transcripts of IGFBP-2 mRNA were detected in both apoptotic and nonapoptotic follicles (Figs. 9, C and D) . In contrast, granulosa cell expression of IGFBP-4 mRNA was restricted to apoptotic follicles (Figs. 9, E and F).
mRNA expression of components of IGF-I system in corpus luteum of PMSG/hCG-treated mice
IGF-I (Fig. 10A) and -II mRNA (not shown) were low or absent in the corpus luteum, whereas transcripts of IGF-IR and IGFBP-2 were easily detected in virtually all luteal cells (Fig. 10, B and C, respectively) . In contrast to the absence of IGFBP-4 mRNA expression in granulosa cells of healthy follicles, its transcript levels increased rapidly in luteinizing cells and were present in some luteal cells following gonadotropin treatment (Fig. 10E) . As mentioned above, IGFBP-3 mRNA expression during follicular development was restricted to a few cells of the thecal compartment in antral follicles. Following ovulation, some cells morphologically identical to those IGFBP-3-positive cells appeared to infiltrate the forming corpus luteum (Fig. 10D ). Other luteal cell types were negative for IGFBP-3 mRNA expression (Fig.  10D) . Similarly, IGFBP-5 transcripts were expressed in some but not all luteal cells (Fig. 10F) .
The cellular localization of transcripts of mouse ovarian IGF system components is summarized in Table 1 .
Discussion
The current work establishes that transcripts of IGF-I, -II, -IR and IGFBP-2 through -5 are expressed in the mouse ovary. However, only the expression of IGF-I and IGFBP-4 and -5 (but not IGFBP-2) mRNA critically change during the course of follicular development. Previous studies have indicated the expression of many of these IGF system compo- nents in murine ovaries (16, 17) but have not provided a complete picture of changes during follicular growth or atresia.
In the current study, the involvement of IGF-I in follicular development is suggested by a rapid increase of its transcript levels as follicle growth progresses toward the antral stage. IGF-I was also linked to follicular survival in the current study, because the levels of IGF-I mRNA were inversely correlated with atresia as determined morphologically. It has been shown that apoptotic cell death with accompanying DNA fragmentation is the molecular mechanism underlying the initiation and progression of follicular atresia (32) . Our results show that early apoptosis was not always associated with a decrease in IGF-I transcript levels. In fact a decrease in IGF-I mRNA was only detected once morphological signs of atresia had developed. Therefore, a decrease in IGF-I mRNA levels is likely a consequence, rather than a cause of granulosa cell apoptosis. It has been previously reported that follicular development becomes arrested at the early antral stage in IGF-I null mutant mice (1). That study (1) and another (17) indicate that IGF-I regulates antrum formation and FSH action (increased aromatase activity) in granulosa cells of antral follicles. Collectively, these observations clearly demonstrate a requirement for IGF-I in follicular development beyond the antral stage. However, IGF-I is not essential before antrum formation because preantral follicles can develop in IGF-I knockout mice (1) . Nonetheless, the presence of IGF-IR transcripts in granulosa cells of preantral follicles suggests earlier development of IGF responsivity. It is noteworthy that early stages of follicular development, e.g. primary follicles, which are characterized by a low growth rate (34, 35) , were associated with low IGF-I expression in our 
IGF IN GROWING AND ATRETIC MOUSE OVARIAN FOLLICLES
study, whereas IGF-I increased to a maximum in rapidly growing large preantral and early antral follicles (34, 35) . Together, these observations suggest that IGF-I may be rate limiting for preantral follicle development.
In contrast to the studies with IGF-I, few previous studies link the IGFBPs to follicular development or death in the mouse. Adashi et al. (1997) noted that IGFBP-2 was expressed predominantly in the granulosa compartment in agreement with our current studies, a situation different than in the rat (16) . However, these authors failed to note a strong positive or negative correlation between IGFBP expression and follicle health or atresia. In contrast, numerous data have linked IGFBP-2 (19), -4 (13, 14) , and -5 (12, 14) with atresia in other species. Surprisingly, granulosa cell IGFBP-2 mRNA expression, which was abundant, failed to correlate with any measure of follicular development or atresia in the current study.
Our current observations that IGFBP-4 mRNA is expressed in granulosa cells of some but not all follicles is consistent with a previous report (16) . In our study, we also determined that IGFBP-4 mRNA expression in granulosa cells was restricted to the same follicles in which apoptotic granulosa cells were detected. Consistent with these results, follicles showing histological signs of atresia also expressed IGFBP-4 transcripts in their granulosa cell compartment. Interestingly, the expression of IGFBP-4 transcripts in granulosa cells preceded the appearance of morphological signs of atresia. Together, these data suggest that IGFBP-4 could be a marker of incipient follicular atresia in the mouse ovary. It is possible that IGFBP-4 promotes follicular atresia by sequestrating IGF-I, thereby reducing its availability to interact with IGF-IR in granulosa cells.
Transcripts of IGFBP-5, like those of IGF-I, were inversely correlated with follicular atresia. In contrast, it has been reported that in the rat ovary, IGFBP-5 mRNA is restricted to atretic preantral follicles (12, 14) . The confinement of IGFBP-5 transcripts to granulosa cells of healthy primary and secondary follicles is remarkable because these follicles have the slowest growth rate (35) and a limited steroidogenic capacity (36) . The capability to synthesize estradiol is acquired by granulosa cells later, during the antral stage, and IGF-I regulates gonadotropin stimulation of aromatase activity (36, 17) . Therefore it is possible that IGFBP-5 prevents the premature differentiation, i.e. steroidogenic capability, of granulosa cells in healthy primary and secondary follicles, perhaps by sequestrating IGF-I. Alternatively, the recent identification of IGFBP-5 receptors in other systems raises the possibility of an IGF-independent action of this binding protein in preantral follicles (37-39).
Our observations suggest that the mouse corpus luteum is a source of all the binding proteins considered (IGFBP-2 through -5) but not of IGF-I or -II. The absence of in situ transcripts of the IGFs and the expression of IGF-IR and IGFBP-2 to -5 to luteal cells suggest that extraovarian IGF-I or -II traveling through the ovarian microvasculature could supply the corpus luteum. In fact, recent studies in humans suggest that extraovarian IGF-IGFBP complexes may reach the ovarian follicular fluid as well (40) . Very little is known about the role of IGFBPs in the regulation of luteal function. It is possible that IGFBP-3 and -5, both of which can form a ternary complex with the IGFs and the acid-labile subunit (41) , target circulating IGF to luteal cells. IGFBP-4 has generally manifested an inhibitory action on the ovary (42) , and in our study, atresia and luteinization were both marked by an increase in IGFBP-4 mRNA and a decrease in IGF-I transcripts in luteal and granulosa cells. Granulosa cells of atretic and luteinizing follicles also produce more progesterone and less estradiol (36) . Collectively, it is possible that IGFBP-4 regulates granulosa cell luteinization, perhaps by sequestrating IGF-I, therefore reducing its availability for IGF-IR. Similarly, in the pig ovary, IGFBP-4 mRNA expression has been reported to increase in preovulatory follicles and to be associated with granulosa cell luteinization (43) .
Although the actions of the IGFBPs in the ovary are incompletely understood, the data from multiple studies suggests that the effects of IGFBP-4 are the most consistently inhibitory (see Ref. 44 for a review). In contrast, IGFBP-2, -3, and -5 have each been shown to exhibit both positive and negative effects on cellular function in a variety of culture systems (44, 45) . Although stimulatory effects of these IGFBPs have not yet been demonstrated in ovarian cells, the correlation of expression of some proteins, e.g. IGFBP-5, with follicular growth and development suggests that this may be plausible in vivo.
In summary, we demonstrated that critical changes occur in the level of expression of IGF-I and IGFBP-4 and -5 genes during follicular growth and atresia in mice. Changes in IGF-I transcripts parallel the ability of preantral follicles to move from a slow to a rapid growth phase. During this period of slow growth, IGFBP-5 is strongly expressed, suggesting that it may regulate IGF effects. A major finding of this study is that IGFBP-4 is an atretogenic candidate for mouse ovarian follicles; the appearance of its transcripts in granulosa cells coincides with the hallmark of apoptosis (DNA fragmentation) and precedes morphological signs of follicular atresia. 
